3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Genitourinary
1
Conditions
Prostatic Neoplasms
11
Carcinoma, Renal Cell
10
Breast Neoplasms
6
Urinary Bladder Neoplasms
5
Melanoma
4
Neoplasm Metastasis
3
Lymphoma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Wilms Tumor
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Liver Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
testosterone undecanoate
1
tempol
1
TEMPOL-H
1
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Gonadotropins
1
Diet, Protein-Restricted
1
Dasatinib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostate Cancer Recurrent
×
Sirolimus
×
Genitourinary
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled